Over time, as functional renal tissue in PKD patients further diminishes and EPO production decreases [20], the transplanted kidney gradually becomes the primary source of EPO, reducing the differences in anemia between PKD and non-PKD patients. This evidence concerns the gene EPO and anemia (phenotype).